[Form 4] The Vita Coco Company, Inc. Insider Trading Activity
Michael Kirban, Executive Chairman and director of The Vita Coco Company, Inc. (COCO), reported insider transactions on Form 4. The filing shows a sale of 30,000 shares of common stock on 09/09/2025 effected pursuant to a Rule 10b5-1 trading plan at a weighted average price of $39.161 per share. The form also records a disposition of 127,629 shares and reports post-transaction beneficial ownership figures including 1,599,049 shares indirectly beneficially owned by Mr. Kirban and 615,681 shares held indirectly by the Michael Kirban Revocable Trust. The filing discloses multiple outstanding non-qualified stock options with exercise prices from $10.178 to $32.78 and vesting schedules through 2036, several of which are fully vested and currently exercisable.
Michael Kirban, presidente esecutivo e amministratore di The Vita Coco Company, Inc. (COCO), ha riportato operazioni insider sul modulo 4. Il deposito mostra la vendita il 09/09/2025 di 30.000 azioni ordinarie effettuata nell’ambito di un piano di trading Rule 10b5-1 al prezzo medio ponderato di 39,161 dollari per azione. Il modulo registra anche una disposizione di 127.629 azioni e riporta le cifre di proprietà beneficiaria post-transazione, tra cui 1.599.049 azioni indirettamente possedute dal signor Kirban e 615.681 azioni detenute indirettamente dal Michael Kirban Revocable Trust. Il deposito rivela multiple stock option non qualificate rimaste in essere con prezzi di esercizio da 10,178 a 32,78 dollari e piani di vesting fino al 2036, alcuni dei quali sono completamente vestiti e attualmente esercitabili.
Michael Kirban, presidente ejecutivo y director de The Vita Coco Company, Inc. (COCO), informó transacciones de insider en el Formulario 4. La presentación muestra la venta de 30.000 acciones ordinarias el 09/09/2025 realizada conforme a un plan de negociación Rule 10b5-1 a un precio medio ponderado de 39,161 dólares por acción. El formulario también registra una disposición de 127.629 acciones y reporta las cifras de propiedad beneficiaria post-transacción, incluyendo 1.599.049 acciones indirectamente poseídas por el Sr. Kirban y 615.681 acciones mantenidas indirectamente por el Michael Kirban Revocable Trust. El documento revela múltiples opciones sobre acciones no calificadas vigentes con precios de ejercicio desde 10,178 a 32,78 dólares y calendarios de vesting hasta 2036, varias de las cuales están completamente adquiridas y actualmente exercitables.
마이클 커반은 The Vita Coco Company, Inc. (COCO)의 실행 의장 겸 이사를 역임하며 Form 4에 내부자 거래를 보고했습니다. 공시는 2025년 9월 9일에 Rule 10b5-1 거래 계획에 따라 가중 평균 가격 39.161달러로 보통주 30,000주를 매도한 것을 보여줍니다. 또한 127,629주의 처분이 기록되며 거래 후의 수익 귀속 보유 수치로 커반 씨가 간접적으로 보유한 1,599,049주와 Michael Kirban Revocable Trust가 간접 보유한 615,681주가 보고됩니다. 공시는 행사 가격 10.178달러에서 32.78달러까지의 여러 비자격 주식 옵션이 남아 있으며 2036년까지의 취득 일정이 있으며, 다수는 이미 완전히 취득되어 현재 행사 가능합니다.
Michael Kirban, président exécutif et administrateur de The Vita Coco Company, Inc. (COCO), a déclaré des transactions d’initiés sur le formulaire 4. Le dépôt indique la vente de 30 000 actions ordinaires le 09/09/2025 réalisée dans le cadre d’un plan de négociation Rule 10b5-1 à un cours moyen pondéré de 39,161 dollars par action. Le formulaire enregistre également une cession de 127 629 actions et indique des chiffres de propriété bénéficiaire post-transaction, dont 1 599 049 actions indirectement détenues par M. Kirban et 615 681 actions détenues indirectement par le Michael Kirban Revocable Trust. Le dépôt révèle plusieurs options d’achat d’actions non qualifiées en cours d’exercice avec des prix d’exercice allant de 10,178 à 32,78 dollars et des calendriers de vesting jusqu’en 2036, dont plusieurs sont entièrement acquises et actuellement exerçables.
Michael Kirban, Vorstandsvorsitzender und Direktor von The Vita Coco Company, Inc. (COCO), hat Insider-Transaktionen im Formular 4 gemeldet. Die Einreichung zeigt den Verkauf von 30.000 Stammaktien am 09.09.2025, durchgeführt im Rahmen eines Rule 10b5-1-Handelsplans zu einem durchschnittlich gewichteten Preis von 39,161 USD pro Aktie. Das Formular verzeichnet auch eine Abgabe von 127.629 Aktien und meldet nachtransaktionale Eigentumsverhältnisse, darunter 1.599.049 Aktien, die von Herrn Kirban indirekt gehalten werden, und 615.681 Aktien, die indirekt vom Michael Kirban Revocable Trust gehalten werden. Die Einreichung deckt außerdem mehrere bestehende nicht qualifizierte Aktienoptionen mit Ausübungspreisen von 10,178 bis 32,78 USD auf und Vesting-Pläne bis 2036, von denen mehrere vollständig vestet und derzeit ausübbar sind.
مايكل كيربان، رئيس مجلس الإدارة التنفيذي ومدير شركة The Vita Coco Company, Inc. (COCO)، قد قدّم معاملات داخلية في النموذج 4. يُظهر الإيداع بيع 30,000 سهم من الأسهم العادية في 09/09/2025 بموجب خطة تداول Rule 10b5-1 بسعر سعر مرجح وزني قدره 39.161 دولارًا للسهم. كما يسجّل النموذج تخصيص 127,629 سهمًا ويذكر أرقام الملكية المستفيدة بعد الصفقة بما في ذلك 1,599,049 سهمًا مملوكًا بشكل غير مباشر للسيد كيربان و615,681 سهمًا مملوكة بشكل غير مباشر بواسطة Michael Kirban Revocable Trust. يكشف الإيداع عن عدة خيارات أسهم غير مؤهلة لا تزال سارية مع أسعار ممارسة من 10.178 إلى 32.78 دولار وتواريخ الاستحقاق حتى 2036، والعديد منها مكتملة الملكية حاليًا وقابلة للممارسة.
迈克尔·基尔班，The Vita Coco Company, Inc.（COCO）的执行主席兼董事，已在 Form 4 上披露内幕交易。 该备案显示在2025年9月9日通过 Rule 10b5-1 交易计划以加权平均价格每股39.161美元，出售30,000股普通股。该表还记录了127,629股的处置，并报告交易后的受益所有权数字，其中迈克尔·基尔班间接拥有1,599,049股，Michael Kirban Revocable Trust间接持有615,681股。备案还披露若干未资格认定的股票期权，行使价格从10.178美元至32.78美元，归属期延续至2036年，其中多项已经完全归属并且当前可行使。
- Sale executed under Rule 10b5-1 plan, indicating the transaction followed a pre-established trading program
- Detailed disclosure of option grants and vesting schedules, including several fully vested and exercisable tranches
- Insider dispositions reported: sale of 30,000 shares at a weighted average $39.161 and an additional disposition of 127,629 shares
- Significant outstanding options (totaling multiple tranches up to 546,000 shares) which could lead to future share issuance upon exercise
Insights
TL;DR: Insider completed a Rule 10b5-1 sale of 30,000 shares; significant option holdings remain outstanding.
The Form 4 documents a planned sale of 30,000 shares under a Rule 10b5-1 plan at a weighted average price of $39.161 and a separate reported disposition of 127,629 shares. Post-transaction beneficial ownership is disclosed as 1,599,049 shares indirect and 615,681 shares held by a revocable trust. The filing lists multiple non-qualified stock options with specified exercise prices and vesting timelines, including several fully vested and exercisable tranches. For investors, the combination of disclosed sales and remaining vested options is relevant for share supply considerations, while the Rule 10b5-1 designation indicates the sale followed a pre-established plan.
TL;DR: Sale executed under a 10b5-1 plan; disclosure is thorough with option vesting detail.
The reporting provides explicit compliance signaling by noting the Rule 10b5-1 trading plan for the 30,000-share sale and includes detailed option schedules and vesting provisions. The form identifies indirect ownership through a revocable trust and shows that several stock options are fully vested and exercisable. These disclosures address transparency expectations for insider transactions and executive compensation instruments, allowing stakeholders to assess potential future insider-driven share issuance.
Michael Kirban, presidente esecutivo e amministratore di The Vita Coco Company, Inc. (COCO), ha riportato operazioni insider sul modulo 4. Il deposito mostra la vendita il 09/09/2025 di 30.000 azioni ordinarie effettuata nell’ambito di un piano di trading Rule 10b5-1 al prezzo medio ponderato di 39,161 dollari per azione. Il modulo registra anche una disposizione di 127.629 azioni e riporta le cifre di proprietà beneficiaria post-transazione, tra cui 1.599.049 azioni indirettamente possedute dal signor Kirban e 615.681 azioni detenute indirettamente dal Michael Kirban Revocable Trust. Il deposito rivela multiple stock option non qualificate rimaste in essere con prezzi di esercizio da 10,178 a 32,78 dollari e piani di vesting fino al 2036, alcuni dei quali sono completamente vestiti e attualmente esercitabili.
Michael Kirban, presidente ejecutivo y director de The Vita Coco Company, Inc. (COCO), informó transacciones de insider en el Formulario 4. La presentación muestra la venta de 30.000 acciones ordinarias el 09/09/2025 realizada conforme a un plan de negociación Rule 10b5-1 a un precio medio ponderado de 39,161 dólares por acción. El formulario también registra una disposición de 127.629 acciones y reporta las cifras de propiedad beneficiaria post-transacción, incluyendo 1.599.049 acciones indirectamente poseídas por el Sr. Kirban y 615.681 acciones mantenidas indirectamente por el Michael Kirban Revocable Trust. El documento revela múltiples opciones sobre acciones no calificadas vigentes con precios de ejercicio desde 10,178 a 32,78 dólares y calendarios de vesting hasta 2036, varias de las cuales están completamente adquiridas y actualmente exercitables.
마이클 커반은 The Vita Coco Company, Inc. (COCO)의 실행 의장 겸 이사를 역임하며 Form 4에 내부자 거래를 보고했습니다. 공시는 2025년 9월 9일에 Rule 10b5-1 거래 계획에 따라 가중 평균 가격 39.161달러로 보통주 30,000주를 매도한 것을 보여줍니다. 또한 127,629주의 처분이 기록되며 거래 후의 수익 귀속 보유 수치로 커반 씨가 간접적으로 보유한 1,599,049주와 Michael Kirban Revocable Trust가 간접 보유한 615,681주가 보고됩니다. 공시는 행사 가격 10.178달러에서 32.78달러까지의 여러 비자격 주식 옵션이 남아 있으며 2036년까지의 취득 일정이 있으며, 다수는 이미 완전히 취득되어 현재 행사 가능합니다.
Michael Kirban, président exécutif et administrateur de The Vita Coco Company, Inc. (COCO), a déclaré des transactions d’initiés sur le formulaire 4. Le dépôt indique la vente de 30 000 actions ordinaires le 09/09/2025 réalisée dans le cadre d’un plan de négociation Rule 10b5-1 à un cours moyen pondéré de 39,161 dollars par action. Le formulaire enregistre également une cession de 127 629 actions et indique des chiffres de propriété bénéficiaire post-transaction, dont 1 599 049 actions indirectement détenues par M. Kirban et 615 681 actions détenues indirectement par le Michael Kirban Revocable Trust. Le dépôt révèle plusieurs options d’achat d’actions non qualifiées en cours d’exercice avec des prix d’exercice allant de 10,178 à 32,78 dollars et des calendriers de vesting jusqu’en 2036, dont plusieurs sont entièrement acquises et actuellement exerçables.
Michael Kirban, Vorstandsvorsitzender und Direktor von The Vita Coco Company, Inc. (COCO), hat Insider-Transaktionen im Formular 4 gemeldet. Die Einreichung zeigt den Verkauf von 30.000 Stammaktien am 09.09.2025, durchgeführt im Rahmen eines Rule 10b5-1-Handelsplans zu einem durchschnittlich gewichteten Preis von 39,161 USD pro Aktie. Das Formular verzeichnet auch eine Abgabe von 127.629 Aktien und meldet nachtransaktionale Eigentumsverhältnisse, darunter 1.599.049 Aktien, die von Herrn Kirban indirekt gehalten werden, und 615.681 Aktien, die indirekt vom Michael Kirban Revocable Trust gehalten werden. Die Einreichung deckt außerdem mehrere bestehende nicht qualifizierte Aktienoptionen mit Ausübungspreisen von 10,178 bis 32,78 USD auf und Vesting-Pläne bis 2036, von denen mehrere vollständig vestet und derzeit ausübbar sind.
FAQ
What did Michael Kirban report on the Form 4 for COCO?
Was the 30,000-share sale by Michael Kirban part of a pre-arranged plan?
Does Michael Kirban hold exercisable options disclosed on the Form 4?
How many shares does the Michael Kirban Revocable Trust hold according to the filing?
Who signed the Form 4 on behalf of Michael Kirban?
